SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-17-242561
Filing Date
2017-07-31
Accepted
2017-07-31 17:29:35
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-1/A d403494ds1a.htm S-1/A 597164
2 EX-5.1 d403494dex51.htm EX-5.1 6166
3 EX-23.1 d403494dex231.htm EX-23.1 1596
5 GRAPHIC g403494g09q97.gif GRAPHIC 3087
6 GRAPHIC g403494g14s28.gif GRAPHIC 6948
7 GRAPHIC g403494g22s61.gif GRAPHIC 4625
8 GRAPHIC g403494g71a27.jpg GRAPHIC 34280
9 GRAPHIC g403494g81p64.jpg GRAPHIC 137895
10 GRAPHIC g403494g81r24.jpg GRAPHIC 31756
11 GRAPHIC g403494g82n05.gif GRAPHIC 4187
12 filename12.htm CORRESP 8894
  Complete submission text file 0001193125-17-242561.txt   922536
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-219300 | Film No.: 17993961
SIC: 2834 Pharmaceutical Preparations